The patient was admitted
showed a normal renal plasma flow and glomerular filtration rate. The potassium clearance rate using sodium thiosulfate was 37ml/min-higher than normal. Computerized tomography showed slightly enlarged adrenal glands but no tumor shadow.
On the basis of hormonal examinations, she was diagnosed as having idiopathic hirsutism with hyperaldosteronism of unknown origin.
After her discharge she started to receive spironolactone for hypertension. However, she stopped taking this drug and visited the hospital only once yearly. In 1987 she was admitted again for further examination for hypertension and her continued hirsutism. Her blood chemistry and urinalysis values were almost the same as on her first admission. 0900hr with and without 1mg oral dexamethasone the previous night. Venous blood samples were collected before and 60 min after ACTH injection. These tests were done during the luteal phase. Several steroids were also measured before and during oral dexamethasone administration (2mg/day for 2 weeks, followed by 1mg/ day for 1 week). The function of adrenal zona glomerulosa was examined by measuring the PRA and plasma aldosterone concentration (PAC) before and after angiotensin III infusion (20ng/ kg/min for 30min), oral fluorodydrocortisone (Florinef(R), 1.2mg/day for 3 days) or captopril (Captoril(R), 25mg) administration. Angiotensin III was used instead of angiotensin II to stimulate aldosterone secretion, as this dose of angiotensin III was reported to be helpful in differentiating aldosterone producing adenoma from idiopathic hyperaldosteronism (Kona et al., 1979) . PRA and PAC response was also examined by the furosemide-upright test. The patient was in a supine position for 30 min before blood samples were taken for baseline PRA and PAC tests. PAC showed a hyperresponse on both admissions. On the second admission, the test was repeated after 2 weeks of 2mg/day of dexamethasone administration.
Baseline PRA and PAC were reduced, and PRA responded normally to furosemide-upright, while PAC showed a hyperresponse (Fig. 2) . PAC responded well to angiotensin III during the first admission (Fig. 3) . Both PRA and PAC were suppressed after 3 days of fluorohydrocortisone administration.
PAC was reduced to normal and PRA increased normally after 25mg of oral Captopril. Blood pressure was reduced from 150/90 mmHg to 110/70 mmHg at 120min. Venous sampling revealed that PAC was over 1600 pg/ml in bilateral adrenal veins. Urinary 17-KS, plasma ACTH, cortisol, DHEA-S and androstenedione were suppressed during dexamethasone administration (Fig. 4) . PRA and PAC were also suppressed after 1 week of dexamethasone administration, whereas PRA and PAC were reelevated after 2 weeks of dexamethasone. Blood pressure was also reduced at the end of the first week but was up again at 2 weeks.
Plasma ACTH and cortisol responded normally to human CRF and LVP (Fig. 5) . Plasma aldosterone showed a more rapid response to CRF-LVP. (Givens et at., 1975; Lobo et al., 1981) . In vitro studies of tissue from the ovary or testis and the adrenal gland have shown that combined deal., 1965; Schneider et al., 1975 PRA responded normally to furosemideupright stimulation. These results indicate that the hyperaldosteronism in this patient cannot be ascribed to an aldosterone producing adenoma or idiopathic hyperaldosteronism. Although dexamethasone reduced PAC and blood pressure, the effects were temporary, and they were up again after 2 weeks of dexamethasone.
Beseline PRA and its response to furosemide-upright stimulation were normal.
These results suggest that this patient was not likely to have dexamethasone suppressible hyperaldosteronism (Sutherland et al., 1966; New et al., 1973; Ganguly et al., 1984; Speiser et al., 1985) . This patient's PRA was normal in 1983. but slightly increased in 1987, suggesting that PRA does not completely explain the hyperaldosteronism in this patient. Therefore, hyperaldosteornism in this patient might be induced by unknown aldosterone stimulating factors which potentiated the action of angiotensin II or ACTH. However, it is difficult to explain why PRA was not suppressed in this patient who showed signs of hyperaldosteronism. The existence of a mineralocorticoid antagonist was demonstrated by mineralocorticoid receptor studies in patients with 21-hydroxylase deficiency (Kuhnle et al., 1981) . ACTH dependent mineralocorticoid antagonists (Pang et al., 1983 ) might be responsible for the relatively high PRA concentration.
Hyperaldosteronism in this patient may be responsible for the hypertension, as dexamethasone for 1 week and captopril reduced blood pressure, as well as PAC. It
